Southampton, UK-based start-up Curve Therapeutics has completed a £40.5 million ($51 million) in Series A financing for its drug discovery platform that enables drug screening within cells. The round ...

This year’s BIO International Convention, held mid-June in Boston, took place against a backdrop dominated by global events. Such events are always liable to send unwelcome shudders through the ...

Over the past decade, however, a wave of technological advances has begun to expand the druggable proteome. These include covalent inhibitors (such as sotorasib), chemical proteomics, and AI-enabled ...